Development of Therapeutics and Diagnostics for Biodefense Program

by: Michael Saunders

The National Institutes of Health, otherwise termed as NIH, is an agency operating within the United States Department of Health and Human Services that is generally responsible for financially supporting the country's biomedical and health-related research studies.

The initiatives of the NIH are all geared towards the realization its primary agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In keeping with this mission, the National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

NIAID Category A, B, and C priority agents are pathogens that can be used as a biological weapon in acts of terrorism or sabotage. The examples of these pathogens are the ones that cause, anthrax, botulism, plague, smallpox, tularemia, hemorrhagic fevers, melioidosis, brucellosis, typhus fever, yellow fever, rabies, and several others.

The goal of the Development of Therapeutics and Diagnostics for Biodefense is to solicit applications from eligible participants in order to further explore the options and strategies that can lead to the treatment or diagnosis of the diseases that are mentioned above.

  (continued...)

Development of Therapeutics and Diagnostics for Biodefense Program
  Page 2

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on artist grants and children grants.

Additional Resources

category - Health Grants

Minority-Based Community Clinical Oncology Program Groups
In line with this mission, the National Institutes of Health has recently collaborated with the National Cancer Institute (NCI) in an attempt to establish the Minority-Based Community Clinical Oncology Program Groups (MBCCOP).

---

OMICS Technologies For Predictive Modeling of Infectious Diseases Program
In keeping with this mission, the National Institutes of Health has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) in an attempt to establish the OMICS Technologies For Predictive Modeling of Infectious Diseases Program.

---

Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program
In keeping with this mission, the National Institutes of Health has partnered with the Canadian Institutes of Health Research (CIHR), the National Heart, Lung, and Blood Institute (NHLBI), and the Institute of Circulatory and Respiratory Health (ICRH) to establish the Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program.

---

Health Resources and Services Administration: HIV Care Grant Program, Part B
Part B of the HIV Care Grant Program is designed to develop or improve the people's access to a comprehensive continuum of high-quality, community-based care for low-income patients diagnosed with HIV.

---